335 related articles for article (PubMed ID: 36964659)
21. Gene Modulation with CRISPR-based Tools in Human iPSC-Cardiomyocytes.
Han JL; Entcheva E
Stem Cell Rev Rep; 2023 May; 19(4):886-905. PubMed ID: 36656467
[TBL] [Abstract][Full Text] [Related]
22. Application of CRISPR-Cas systems in neuroscience.
Bonnerjee D; Bagh S
Prog Mol Biol Transl Sci; 2021; 178():231-264. PubMed ID: 33685599
[TBL] [Abstract][Full Text] [Related]
23. Applications of CRISPR/Cas System to Bacterial Metabolic Engineering.
Cho S; Shin J; Cho BK
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29621180
[TBL] [Abstract][Full Text] [Related]
24. CRISPR based therapeutics: a new paradigm in cancer precision medicine.
Das S; Bano S; Kapse P; Kundu GC
Mol Cancer; 2022 Mar; 21(1):85. PubMed ID: 35337340
[TBL] [Abstract][Full Text] [Related]
25. CRISPR technologies for stem cell engineering and regenerative medicine.
Hsu MN; Chang YH; Truong VA; Lai PL; Nguyen TKN; Hu YC
Biotechnol Adv; 2019 Dec; 37(8):107447. PubMed ID: 31513841
[TBL] [Abstract][Full Text] [Related]
26. Perspectives on gene expression regulation techniques in Drosophila.
Xu RG; Wang X; Shen D; Sun J; Qiao HH; Wang F; Liu LP; Ni JQ
J Genet Genomics; 2019 Apr; 46(4):213-220. PubMed ID: 31060819
[TBL] [Abstract][Full Text] [Related]
27. CRISPR-Cas tools to study gene function in cytokinesis.
Husser MC; Skaik N; Martin VJJ; Piekny A
J Cell Sci; 2021 Apr; 134(8):. PubMed ID: 33912919
[TBL] [Abstract][Full Text] [Related]
28. Generation and validation of CRISPR-engineered human natural killer cell lines for research and therapeutic applications.
Kumar A; Lee SJ; Liu Q; Chan AKN; Pokharel SP; Yu J; Chen CW; Swaminathan S
STAR Protoc; 2021 Dec; 2(4):100874. PubMed ID: 34746857
[TBL] [Abstract][Full Text] [Related]
29. CRISPR-Based Approaches for Gene Regulation in Non-Model Bacteria.
Call SN; Andrews LB
Front Genome Ed; 2022; 4():892304. PubMed ID: 35813973
[TBL] [Abstract][Full Text] [Related]
30. CAMERS-B: CRISPR/Cpf1 assisted multiple-genes editing and regulation system for Bacillus subtilis.
Wu Y; Liu Y; Lv X; Li J; Du G; Liu L
Biotechnol Bioeng; 2020 Jun; 117(6):1817-1825. PubMed ID: 32129468
[TBL] [Abstract][Full Text] [Related]
31. Beyond editing: repurposing CRISPR-Cas9 for precision genome regulation and interrogation.
Dominguez AA; Lim WA; Qi LS
Nat Rev Mol Cell Biol; 2016 Jan; 17(1):5-15. PubMed ID: 26670017
[TBL] [Abstract][Full Text] [Related]
32. Development and implementation of a Type I-C CRISPR-based programmable repression system for
Geslewitz WE; Cardenas A; Zhou X; Zhang Y; Criss AK; Seifert HS
mBio; 2024 Feb; 15(2):e0302523. PubMed ID: 38126782
[TBL] [Abstract][Full Text] [Related]
33. CRISPR/Cas9 Genome Editing: A Promising Tool for Therapeutic Applications of Induced Pluripotent Stem Cells.
Zhang Y; Sastre D; Wang F
Curr Stem Cell Res Ther; 2018; 13(4):243-251. PubMed ID: 29446747
[TBL] [Abstract][Full Text] [Related]
34. The CRISPR toolbox for the gram-positive model bacterium
Zocca VFB; Corrêa GG; Lins MRDCR; de Jesus VN; Tavares LF; Amorim LADS; Kundlatsch GE; Pedrolli DB
Crit Rev Biotechnol; 2022 Sep; 42(6):813-826. PubMed ID: 34719304
[TBL] [Abstract][Full Text] [Related]
35. A review on CRISPR/Cas-based epigenetic regulation in plants.
Jogam P; Sandhya D; Alok A; Peddaboina V; Allini VR; Zhang B
Int J Biol Macromol; 2022 Oct; 219():1261-1271. PubMed ID: 36057300
[TBL] [Abstract][Full Text] [Related]
36. Plant-Based Biosensors for Detecting CRISPR-Mediated Genome Engineering.
Yuan G; Hassan MM; Yao T; Lu H; Vergara MM; Labbé JL; Muchero W; Pan C; Chen JG; Tuskan GA; Qi Y; Abraham PE; Yang X
ACS Synth Biol; 2021 Dec; 10(12):3600-3603. PubMed ID: 34878784
[TBL] [Abstract][Full Text] [Related]
37. Recent advances in CRISPR technologies for genome editing.
Song M; Koo T
Arch Pharm Res; 2021 Jun; 44(6):537-552. PubMed ID: 34164771
[TBL] [Abstract][Full Text] [Related]
38. Evolution of CRISPR/Cas Systems for Precise Genome Editing.
Hryhorowicz M; Lipiński D; Zeyland J
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762535
[TBL] [Abstract][Full Text] [Related]
39. Research Techniques Made Simple: The Application of CRISPR-Cas9 and Genome Editing in Investigative Dermatology.
Guitart JR; Johnson JL; Chien WW
J Invest Dermatol; 2016 Sep; 136(9):e87-e93. PubMed ID: 27542298
[TBL] [Abstract][Full Text] [Related]
40. Expanding the Scope of Bacterial CRISPR Activation with PAM-Flexible dCas9 Variants.
Kiattisewee C; Karanjia AV; Legut M; Daniloski Z; Koplik SE; Nelson J; Kleinstiver BP; Sanjana NE; Carothers JM; Zalatan JG
ACS Synth Biol; 2022 Dec; 11(12):4103-4112. PubMed ID: 36378874
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
